-
News Summary for July 29, 2011
Friday, July 29, 2011 - 7:52am | 542This is your Benzinga news summary and traders' outlook for Friday, July 29, 2011, covering headlines from overnight and Friday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading lower as traders worry about when the decision on the debt ceiling will be...
-
Bank of America Comments on Eli Lilly
Friday, July 29, 2011 - 7:46am | 119Bank of America has published a report on Eli Lilly & Co (NYSE: LLY). In the report, Bank of America wrote, "A large majority of docs (72%) expect their TRT prescribing to grow over the next year, while the rest expect stable prescribing. Rising patient awareness, testing, and new drugs were...
-
Bank of America Reviews a Survey on Auxilium Pharmaceutical
Friday, July 29, 2011 - 7:23am | 129Bank of America has published a report on Auxilium Pharmaceuticals (NASDAQ: AUXL) reviewing the results of a survey the bank had commissioned. In the report, Bank of America wrote, "We commissioned a survey of 75 docs that treat hypogonadism (low testosterone) to help assess the outlook for AUXL's...
-
Piper Jaffray Lowers PT On 3D Systems To $15
Friday, July 29, 2011 - 7:05am | 27Piper Jaffray has lowered the price target on 3D Systems (NYSE: DDD) from $19 to $15 and maintains its Underweight rating.
-
US Stock Futures Down On Debt Worries
Friday, July 29, 2011 - 6:13am | 527US stock futures are lower this morning, after Thursday's House budget vote on the US debt ceiling was rescheduled. Futures for the Dow Jones Industrial Average dipped 55 points to 12,138.00 and S&P 500 index futures fell 5.70 points to 1,291.10. Nasdaq 100 futures dropped 7.75 points to 2,362....
-
Earnings Scheduled For July 29
Friday, July 29, 2011 - 4:18am | 424Chevron Corporation (NYSE: CVX) is projected to report its Q2 EPS at $3.56 on revenue of $71.58 billion. Aon Corporation (NYSE: AON) is expected to report its Q2 EPS at $0.82 on revenue of $2.74 billion. Newell Rubbermaid Inc (NYSE: NWL) is estimated to report its Q2 EPS at $0.42 on revenue of $...
-
Stocks To Watch For July 29
Friday, July 29, 2011 - 3:39am | 259Some of the stocks that may grab investor focus today are: Wall Street expects Merck & Company Inc (NYSE: MRK) to report its Q2 EPS at $0.95 on revenue of $11.78 billion. Merck shares dropped 0.74% to close at $34.93 yesterday. Starbucks Corp (NASDAQ: SBUX) reported its Q2 profit at $279...
-
High Yield Birth Control Stocks
Thursday, July 28, 2011 - 9:45pm | 613An Institute of Medicine medical advisory panel recently recommended to the Health and Human Services Department that contraception should qualify as preventive care. Since insurers must fully cover the cost of preventative care under the new health care law, then everyone would have access to free...
-
Stocks Going Ex Dividend the Second Week of August
Thursday, July 28, 2011 - 5:58pm | 728Here is our latest update on the stock trading technique called 'Buying Dividends'. This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only...
-
Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
Thursday, July 28, 2011 - 5:01pm | 188Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) today confirmed that the U.S. Food and Drug Administration approved dosing recommendations for OFIRMEV injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg. Cadence's announcement follows the issuance of a news release...
-
Pfizer Earnings Preview: Analysts Expect Falling EPS
Thursday, July 28, 2011 - 3:40pm | 569Pfizer (NYSE: PFE) announces its next round of earnings this Tuesday, August 2, 2011. Here is Benzinga's everything-that-matters guide for this Tuesday's second quarter earnings announcement. Earnings and Revenue: Based on estimates, investors are readying for a positive EPS reading of 59...
-
Gridlock Continues 07-28-2011
Thursday, July 28, 2011 - 2:52pm | 1096Cusick Corner Gridlock continues and hedging was the name of the game. This will be short because this budget impasse makes trading or investing dicey at best. If we go into the weekend with no resolution and more politicking, volatility will continue to grow and further uncertainty will turn into...
-
Icagen Stockholders Contest Proposed Acquisition Price of $6/share by Pfizer in Letter to Board
Thursday, July 28, 2011 - 2:08pm | 107Merlin Nexus and New Leaf Venture Partners, stockholders in Icagen, Inc. (Nasdaq: ICGN), disclosed today a letter submitted to the Icagen Board contesting the Company's planned acquisition by Pfizer Inc (NYSE: PFE). According to a July 20, 2011 press announcement, Pfizer plans to purchase the 8.3...
-
Teva Announces Launch of Camrese the Authorized Generic of Seasonique
Thursday, July 28, 2011 - 1:38pm | 66Teva Pharmaceuticals USA, the U.S.–based generic arm of Teva Pharmaceuticals (NASDAQ: TEVA) announced that it will sell Camrese as the Authorized Generic of Seasonique® which is also manufactured by Teva Pharmaceuticals. This product will continue to be manufactured under the brand product's new...
-
NASDAQ Winners July 27th: Marshall Edwards, Novogen, Acxiom, IAC
Thursday, July 28, 2011 - 11:28am | 506POINT ROBERTS, July 28, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 27, 2011. Thursday, Oncology Company, Marshall Edwards, Inc topped the market winners with a gain of over 135%. Marshall...